Financial Avengers’s Bristol-Myers Squibb BMY Stock Holding History

Financial Avengers’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.11K	Buy	141 +2	+1%	+$115	﹤0.01%	120
2026 Q1	$8.45K	Buy	139 +1	+0.7%	+$58	﹤0.01%	114
2025 Q4	$7.43K	Buy	138 +2	+1%	+$96	﹤0.01%	114
2025 Q3	$6.13K	Buy	136 +2	+1%	+$93	﹤0.01%	121
2025 Q2	$6.2K	Buy	134 +2	+2%	+$98	﹤0.01%	119
2025 Q1	$8.07K	Buy	132 +1	+0.8%	+$58	﹤0.01%	117
2024 Q4	$7.41K	Buy	131 +1	+0.8%	+$56	﹤0.01%	131
2024 Q3	$6.71K	Buy	130 +2	+2%	+$94	﹤0.01%	145
2024 Q2	$5.32K	Buy	128 +2	+2%	+$89	﹤0.01%	130
2024 Q1	$6.69K	Buy	126 +1	+0.8%	+$51	﹤0.01%	118
2023 Q4	$6.4K	Buy	125 +2	+2%	+$105	﹤0.01%	130
2023 Q3	$7.16K	Buy	123 +1	+0.8%	+$61	﹤0.01%	125
2023 Q2	$7.82K	Buy	122 +1	+0.8%	+$67	0.01%	115
2023 Q1	$8.4K	Buy	121 +1	+0.8%	+$71	0.01%	115
2022 Q4	$8.66K	Buy	120 +1	+0.8%	+$75	0.01%	110
2022 Q3	$8K	Hold	119	–	–	0.01%	105
2022 Q2	$9K	Buy	119 +1	+0.8%	+$76	0.01%	112
2022 Q1	$9K	Buy	118 +1	+0.9%	+$67	0.01%	118
2021 Q4	$7K	Buy	117 +1	+0.9%	+$59	﹤0.01%	130
2021 Q3	$7K	Buy	116 +1	+0.9%	+$66	﹤0.01%	127
2021 Q2	$8K	Buy	115 +1	+0.9%	+$65	0.01%	124
2021 Q1	$7K	Buy	114 +1	+0.9%	+$62	0.01%	129
2020 Q4	$7K	Buy	+113	New	+$6.95K	0.01%	126

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Financial Avengers's BMY Position: Q2 2026 in Review

Financial Avengers increased its Bristol-Myers Squibb (BMY) stake by 1.4% in Q2 2026, buying an estimated $115 and bringing the position to 141 shares worth $8.11K. The position accounts for ﹤0.01% of the portfolio, ranked #120.

Financial Avengers first reported a position in BMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $9K in Q2 2022. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Financial Avengers held 141 shares of Bristol-Myers Squibb worth $8.11K as of Q2 2026.
Financial Avengers bought 2 Bristol-Myers Squibb shares in Q2 2026, an estimated $115.
Bristol-Myers Squibb made up ﹤0.01% of Financial Avengers's portfolio in Q2 2026, its #120 holding.
Financial Avengers first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 23 quarters since.
Financial Avengers's Bristol-Myers Squibb position peaked at $9K in Q2 2022.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Financial Avengers's 13F filing for Q2 2026, filed 19 Aug 2026.